Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Breast Cancer Research and Treatment|April 28, 2004
Magnetic resonance imaging in comparison to clinical palpation in assessing the response of breast cancer to epirubicin primary chemotherapyMaria Bodini, Alfredo Berruti, Alberto Bottini, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancerDaniele Generali, Stephen B Fox, Alfredo Berruti, et al.Neuroendocrinology|December 30, 2011
Risk factors for disease progression in advanced jejunoileal neuroendocrine tumorsFrancesco Panzuto, Davide Campana, Nicola Fazio, et al.Journal of Clinical Medicine|May 9, 2020
Perioperative Chemotherapy in Poorly Differentiated Neuroendocrine Neoplasia of the Bladder: A Multicenter AnalysisGiuseppe Lamberti, Maria Pia Brizzi, Sara Pusceddu, et al.Journal of Clinical Medicine|December 23, 2023
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future PerspectivesSara Stumpo, Maria Giovanna Formelli, Irene Persano, et al.BMC Cancer|March 18, 2014
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT studyAlfredo Berruti, Nicola Fazio, Anna Ferrero, et al.Journal of Clinical Medicine|April 13, 2024
Sequencing Treatments in Patients with Advanced Well-Differentiated Pancreatic Neuroendocrine Tumor (pNET): Results from a Large Multicenter Italian CohortFrancesco Panzuto, Elisa Andrini, Giuseppe Lamberti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancerDaniele Generali, Stephen B Fox, Maria Pia Brizzi, et al.Neuroendocrinology|August 31, 2022
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT StudyPiero Ferolla, Alfredo Berruti, Francesca Spada, et al.Endocrine|September 2, 2020
Risk factors for pancreas and lung neuroendocrine neoplasms: a case-control studyLuca Giraldi, Alessia Vecchioni, Greta Carioli, et al.Pageof 6